Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: [89Zr]-Df-Trastuzumab|DIAGNOSTIC_TEST: PET/MRI Imaging
Sponsor: University of Alabama at Birmingham